Cargando…
Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer
Background: Deoxythymidylate kinase (DTYMK) serves as a pyrimidine metabolic rate-limiting enzyme that catalyzes deoxythymidine monophosphate (dTMP) to generate deoxythymidine diphosphate (dTDP). It remains unclear whether DTYMK expression has the potential to predict outcome and immune cell infiltr...
Autores principales: | Lan, Tianfeng, Wang, Yachao, Miao, Jinxin, Guo, Haoran, Wang, Zheng, Wang, Jianyao, Zhang, Chunyang, Yang, Panpan, Zhang, Zhongxian, Dunmall, Louisa Chard, Wang, Yaohe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315941/ https://www.ncbi.nlm.nih.gov/pubmed/35903153 http://dx.doi.org/10.3389/fmolb.2022.887059 |
Ejemplares similares
-
Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers
por: Lan, Tianfeng, et al.
Publicado: (2021) -
A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
por: Zhang, Zifang, et al.
Publicado: (2020) -
Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL
por: Zhou, Wenping, et al.
Publicado: (2023) -
Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR/Cas9 system
por: Miao, Jinxin, et al.
Publicado: (2022) -
Evidence of Omics, Immune Infiltration, and Pharmacogenomics for BATF in a Pan-Cancer Cohort
por: Jia, Chenguang, et al.
Publicado: (2022)